Abstract Dual‐atom catalysts (DACs) with atomic precision remain pivotal for steering peroxymonosulfate (PMS) activation pathways, yet their development is hindered by synthetic universality gaps and elusive bimetallic synergy in governing reactive oxygen species (ROS) selectivity. Herein, a salt‐confinement strategy enables universal synthesis of cobalt‐based heteronuclear diatomic catalysts (CoM‐NC, M = Fe, Cu, Mn, Ni) anchored on nitrogen‐doped carbon (NC), where electronic‐structure engineering unlocks switchable ROS generation. Crucially, heterometal engineering facilitates precise electronic structure modulation of the CoM‐NC active centers, achieving adaptive control over selective PMS activation. The intermediate electronegativity induces ultrastrong Co‐Fe coupling (ICOHP = −0.97 eV for Fe─O bonds—1.2–1.9 fold stronger than Co─O in other CoM‐NC), reducing singlet oxygen ( 1 O 2 ) formation barriers by 28–78% and achieving near‐exclusive selectivity (>99%) toward electron‐rich pollutants oxidation. Among all tested catalysts, the CoFe–NC demonstrates superior performance, achieving a k obs of 1.54 min −1 for carbamazepine degradation—over 11‐fold higher than that of CoNi–NC. This work uncovers the electronic‐level synergy mechanism dictating selective 1 O 2 generation in DACs/PMS systems, providing critical insights for the rational design of high‐performance diatomic catalysts for advanced oxidation processes.
Wang et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: